Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interaction between the mitochondrial adaptor MIRO and the motor adaptor TRAK. | J Biol Chem | 2023 | 37949220 | PubTator, text mining | PubMed |
| Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing. | Med Oncol | 2023 | 37935925 | PubTator, text mining | PubMed |
| Dominant negative variants in KIF5B cause osteogenesis imperfecta via down regulation of mTOR signaling. | PLoS Genet | 2023 | 37934770 | PubTator, text mining | PubMed |
| Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer. | Front Oncol | 2023 | 37927472 | PubTator, text mining | PubMed |
| Pralsetinib-associated pneumonia in RET fusion-positive non-small cell lung cancer. | Support Care Cancer | 2023 | 37924363 | PubTator, text mining | PubMed |
| A covalent inhibitor of the YAP-TEAD transcriptional complex identified by high-throughput screening. | RSC Chem Biol | 2023 | 37920398 | PubTator, text mining | PubMed |
| Autoinhibited kinesin-1 adopts a hierarchical folding pattern. | Elife | 2023 | 37910016 | PubTator, text mining | PubMed |
| Cerebrospinal fluid proteomics in meningitis patients with reactivated varicella zoster virus. | Immun Inflamm Dis | 2023 | 37904697 | PubTator, text mining | PubMed |
| Epigenetic regulation in lung cancer. | MedComm (2020) | 2023 | 37901797 | PubTator, text mining | PubMed |
| Mitochondrial transport in neurons and evidence for its involvement in acute neurological disorders. | Front Neurosci | 2023 | 37901436 | PubTator, text mining | PubMed |
| Multi-Trait Exome-Wide Association Study of Back Pain-Related Phenotypes. | Genes (Basel) | 2023 | 37895311 | PubTator, text mining | PubMed |
| Selpercatinib and capmatinib combination promotes sustained complete response in novel ISOC1-RET fusion lung cancer after resistance to RET inhibitor via MET amplification: Case Report. | Front Oncol | 2023 | 37876974 | PubTator, text mining | PubMed |
| First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC. | N Engl J Med | 2023 | 37870973 | PubTator, text mining | PubMed |
| First-line versus second-line use of pralsetinib in treatment of rearranged during transfection (RET) fusion-positive advanced non-small cell lung cancer: a cost-effectiveness analysis. | Transl Lung Cancer Res | 2023 | 37854153 | PubTator, text mining | PubMed |
| An allosteric switch between the activation loop and a c-terminal palindromic phospho-motif controls c-Src function. | Nat Commun | 2023 | 37848415 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Multifaceted functions of Drp1 in hypoxia/ischemia-induced mitochondrial quality imbalance: from regulatory mechanism to targeted therapeutic strategy. | Mil Med Res | 2023 | 37833768 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer. | Front Oncol | 2023 | 37810971 | PubTator, text mining | PubMed |
| Extracellular release in the quality control of the mammalian mitochondria. | J Biomed Sci | 2023 | 37805581 | PubTator, text mining | PubMed |
| Mitochondrial transfer in hematological malignancies. | Biomark Res | 2023 | 37798791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=10